Related stocks: Pharmaceutical Preparations
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Related stocks: Pharmaceutical Preparations
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Pharmaceutical preparations company · NV · FY ends Dec · Revenue $3M · -75.05% margin · -$2M FCF
The business is unprofitable at the operating level (-95.23% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 19.0% YoY with margins expanding 72.9pp.
Negative free cash flow of -$2M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$3M
▲ +19.0% YoY
Net Income (TTM)
-$2M
▲ +32.3% YoY
Op. Margin
-75.05%
▲ +72.9pp YoY
ROIC
-33.25%
▲ +8.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$2M
▲ +18.8% YoY
Op. Cash Flow (TTM)
-$2M
▲ +18.8% YoY
Net Debt
-$7M
Net Cash Position
Cash & Equiv.
$7M
5Y CAGR: +46.8%
Continue Research